Pegaptanib Octasodium — CAS 222716-86-1

Pegaptanib Octasodium is a high-purity Active Pharmaceutical Ingredient (API) classified as a VEGF Antagonist / Anti-angiogenic (RNA Aptamer). Manufactured by Mediocon Inc in Aurangabad, Maharashtra, India at a GMP-certified facility, it is supplied in bulk for pharmaceutical formulations worldwide. CAS No: 222716-86-1.

• Neovascular (wet) age-related macular degeneration (AMD)
• Inhibition of VEGF165-mediated ocular angiogenesis
• Macular oedema associated with retinal vein occlusion
• Diabetic macular oedema (investigational)
• Intraocular anti-VEGF therapy

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support